Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients

First Page		Document Content
Date: 2013-12-30 23:23:27 Health Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Cell therapy Immunosuppressive drug Mesenchymal stem cell Stem cell treatments Center for International Blood and Marrow Transplant Research Medicine Biology Stem cells		Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients Add to Reading List Source URL: www.mesoblast.com Download Document from Source Website File Size: 154,24 KB Share Document on Facebook

	Impact of hypertension in the heart Tomáš Seeman Department of Pediatrics and Transplantation Center, University Hospital Motol, 2nd Faculty of Medicine, DocID: 1vqOe - View Document
	An Official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statemen DocID: 1v5F3 - View Document
	Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine Findings support Pluristem’s ongoing Phase I study of PLX-R18 in hematopoietic recovery following hem DocID: 1uys2 - View Document
	International Liver Transplantation Symposium FORTY YEARS IN TRANSPLANTATION « WHAT DID AND WHAT DIDN’T WE REACH » Auditoires Maisin/Lacroix - Faculty of Medicine – UCL / Avenue Mounier, 1200 Woluwe – Brussels ( DocID: 1rRtC - View Document
	Programme Overview Friday 9 September00 DocID: 1rmPf - View Document